CAMK2G and hydrops fetalis: Importantly, treatment of HF myocytes with the CaMKII inhibitor KN93 (1 μM, 15 min) significantly reduced site Ser-2030 phosphorylation levels at basal conditions, and in the presence of phosphatase inhibitor and Iso (Fig. 6E,F).